Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
02 févr. 2022 12h00 HE
|
Organovo, Inc.
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that two of its patents have withstood a patent challenge, and the company provided guidance on...
Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
30 nov. 2021 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
17 sept. 2021 16h10 HE
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
02 mars 2021 08h05 HE
|
Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Organovo Holdings Founder Calls on Board of Directors to Accept Stockholders’ Opposition to the Illogical Merger With Tarveda Therapeutics
02 avr. 2020 08h00 HE
|
Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.
Believes Stockholders Sent a Loud and Clear Message at Special Meeting That They Oppose This Value-Destructive Combination Encourages Board of Directors to Heed Investor Feedback and Re-Focus...
Viscient Biosciences Will Bioprint 3D Lung Tissue to Aid Pandemic Research, and Viscient Founder Calls for Pause in Organovo Merger Attempt
31 mars 2020 15h25 HE
|
Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.
Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19 Organovo failed to...
Organovo Holdings Founder Issues Letter Regarding Alternative Paths to Illogical Merger With Tarveda Therapeutics to Stockholders
23 mars 2020 15h30 HE
|
Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.
Intends to Vote "AGAINST" Proposed Merger With Tarveda Intends to vote “FOR” Reverse Stock Split and Against All Other Provisions Believes the Board, Which Has Presided Over Significant Value...
Organovo Founder Issues Letter to Stockholders Regarding Major Missteps and Misjudgment of the Company’s Board of Directors
19 mars 2020 14h36 HE
|
Keith Murphy, Founder and Concerned Shareholder of Organovo Holdings, Inc.
Intends to Vote "AGAINST" Proposed Merger With Tarveda Believes the Board Has a Track Record of Bad Decisions and Poor Business Judgment Since Mid-2017, Including Hiring a CEO Who Failed Stockholders...